citral has been researched along with Lupus Nephritis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chao, LK; Chen, A; Ho, CL; Hua, KF; Ka, SM; Lin, JC; Lin, TJ; Liu, FC; Sytwu, HK; Yeh, LT | 1 |
1 other study(ies) available for citral and Lupus Nephritis
Article | Year |
---|---|
Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activation.
Topics: Acyclic Monoterpenes; Animals; Carrier Proteins; Cell Line; Cells, Cultured; Disease Models, Animal; Drugs, Chinese Herbal; Female; Inflammasomes; Litsea; Lupus Nephritis; Mice; Mice, Inbred NZB; Monoterpenes; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Severity of Illness Index; Signal Transduction | 2015 |